Recombinant Human IRF2BP2

• Description:

  Recombinant Human IRF2BP2_x000D_ Catalog number: B2017119_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 25 ug_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: N/A_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20℃_x000D_ Keywords: Recombinant Human IRF2BP2_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Chen HH, Keyhanian K, Zhou X, Vilmundarson RO, Almontashiri NA, Cruz SA, Pandey NR, Lerma Yap N, Ho T, Stewart CA, Huang H, Hari A, Geoffrion M, McPherson R, Rayner KJ, Stewart AF. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis Circ Res. 2015 Sep 25;117(8):671-83._x000D_ 2: Chu YH, Wirth LJ, Farahani AA, Nosé V, Faquin WC, Dias-Santagata D, Sadow PM. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization Mod Pathol. 2020 Dec;33(12):2458-2472._x000D_ 3: Sécca C, Faget DV, Hanschke SC, Carneiro MS, Bonamino MH, de-Araujo-Souza PS, Viola JP. IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering J Leukoc Biol. 2016 Nov;100(5):1081-1091._x000D_ 4: Patton A, Speeckaert A, Zeltman M, Cui X, Oghumu S, Iwenofu OH. A novel IRF2BP2::CDX2 Gene fusion in digital intravascular myoepithelioma of soft tissue: An enigma! Genes Chromosomes Cancer. 2023 Mar;62(3):176-183._x000D_ 5: Ukkola I, Nummela P, Kero M, Tammio H, Tuominen J, Kairisto V, Kallajoki M, Haglund C, Peltomäki P, Kytölä S, Ristimäki A. Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers Virchows Arch. 2022 Apr;480(4):807-817._x000D_ 6: Blotta S, Tassone P, Prabhala RH, Tagliaferri P, Cervi D, Amin S, Jakubikova J, Tai YT, Podar K, Mitsiades CS, Zullo A, Franco B, Anderson KC, Munshi NC. Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance Blood. 2009 Oct 8;114(15):3276-84._x000D_ 7: Panagopoulos I, Gorunova L, Bjerkehagen B, Boye K, Heim S. Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma Oncol Rep. 2014 Jul;32(1):40-4._x000D_ 8: Sajjad EA, Sikora K, Paciejewski T, Garbicz F, Paskal W, Szacht M, Grajkowska W, Włodarski PK. Intraparenchymal mesenchymal chondrosarcoma of the frontal lobe--a case report and molecular detection of specific gene fusions from archival FFPE sample Clin Neuropathol. 2015 Sep-Oct;34(5):288-93._x000D_ 9: Ramalho-Oliveira R, Oliveira-Vieira B, Viola JPB. IRF2BP2: A new player in the regulation of cell homeostasis J Leukoc Biol. 2019 Sep;106(3):717-723._x000D_ 10: Kim J, Sim AY, Barua S, Kim JY, Lee JE. Agmatine-IRF2BP2 interaction induces M2 phenotype of microglia by increasing IRF2-KLF4 signaling Inflamm Res. 2023 Jun;72(6):1203-1213. _x000D_ _x000D_ Products Related to Recombinant Human IRF2BP2 can be found at Proteins

• Short Description:

  Catalog Number: B2017119 (25 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5

• CAS Number:

  9000-83-3